Annual Revenue
$396.59 M
+$321.17 M+425.83%
31 December 2023
Summary:
Apellis Pharmaceuticals annual revenue is currently $396.59 million, with the most recent change of +$321.17 million (+425.83%) on 31 December 2023. During the last 3 years, it has risen by +$145.94 million (+58.23%). APLS annual revenue is now at all-time high.APLS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$196.83 M
-$2.85 M-1.43%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly revenue is currently $196.83 million, with the most recent change of -$2.85 million (-1.43%) on 30 September 2024. Over the past year, it has increased by +$86.43 million (+78.29%). APLS quarterly revenue is now -21.27% below its all-time high of $250.00 million, reached on 31 December 2020.APLS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$715.22 M
+$86.43 M+13.75%
30 September 2024
Summary:
Apellis Pharmaceuticals TTM revenue is currently $715.22 million, with the most recent change of +$86.43 million (+13.75%) on 30 September 2024. Over the past year, it has increased by +$442.34 million (+162.10%). APLS TTM revenue is now at all-time high.APLS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +425.8% | +78.3% | +162.1% |
| 3 y3 years | +58.2% | +3383.7% | +179.1% |
| 5 y5 years | - | - | - |
APLS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +495.8% | -1.4% | +3383.7% | at high | +974.5% |
| 5 y | 5 years | at high | +495.8% | -21.3% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | +495.8% | -21.3% | >+9999.0% | at high | >+9999.0% |
Apellis Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $196.83 M(-1.4%) | $715.22 M(+13.7%) |
| June 2024 | - | $199.69 M(+15.9%) | $628.79 M(+20.0%) |
| Mar 2024 | - | $172.32 M(+17.7%) | $524.07 M(+32.1%) |
| Dec 2023 | $396.59 M(+425.8%) | $146.38 M(+32.6%) | $396.59 M(+45.3%) |
| Sept 2023 | - | $110.40 M(+16.2%) | $272.88 M(+47.9%) |
| June 2023 | - | $94.97 M(+111.8%) | $184.53 M(+74.3%) |
| Mar 2023 | - | $44.85 M(+97.9%) | $105.89 M(+40.4%) |
| Dec 2022 | $75.42 M | $22.66 M(+2.8%) | $75.42 M(-33.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $22.06 M(+35.1%) | $113.05 M(+17.0%) |
| June 2022 | - | $16.32 M(+13.5%) | $96.64 M(+19.4%) |
| Mar 2022 | - | $14.38 M(-76.1%) | $80.94 M(+21.6%) |
| Dec 2021 | $66.56 M(-73.4%) | $60.29 M(+967.1%) | $66.56 M(-74.0%) |
| Sept 2021 | - | $5.65 M(+806.9%) | $256.27 M(+2.0%) |
| June 2021 | - | $623.00 K(-99.8%) | $251.27 M(+0.2%) |
| Dec 2020 | $250.65 M | $250.00 M(>+9900.0%) | $250.65 M(>+9900.0%) |
| Sept 2020 | - | $646.00 K | $646.00 K |
FAQ
- What is Apellis Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual revenue year-on-year change?
- What is Apellis Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly revenue year-on-year change?
- What is Apellis Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM revenue year-on-year change?
What is Apellis Pharmaceuticals annual revenue?
The current annual revenue of APLS is $396.59 M
What is the all time high annual revenue for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual revenue is $396.59 M
What is Apellis Pharmaceuticals annual revenue year-on-year change?
Over the past year, APLS annual revenue has changed by +$321.17 M (+425.83%)
What is Apellis Pharmaceuticals quarterly revenue?
The current quarterly revenue of APLS is $196.83 M
What is the all time high quarterly revenue for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly revenue is $250.00 M
What is Apellis Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, APLS quarterly revenue has changed by +$86.43 M (+78.29%)
What is Apellis Pharmaceuticals TTM revenue?
The current TTM revenue of APLS is $715.22 M
What is the all time high TTM revenue for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM revenue is $715.22 M
What is Apellis Pharmaceuticals TTM revenue year-on-year change?
Over the past year, APLS TTM revenue has changed by +$442.34 M (+162.10%)